Kodak reportedly under SEC investigation over disclosure of U.S. drug producing deal PUBLISHED TUE, AUG 4 20201:39 PM EDTUPDATED 2 HOURS AGO Yun Li @YUNLI626 KEY POINTS The SEC is looking into Eastman Kodak’s disclosure about getting awarded a $765 million loan from the U.S. government to start producing drug ingredients, the Wall Street Journal reported.
On July 27, a day before Kodak as well as President Donald Trump announced the deal, shares of the film pioneer soared nearly 25% with trading volumes far exceeding those in previous sessions.
The SEC’s probe, which is still at an early stage, is focused on how Kodak disclosed the deal with the government, the Journal reported, citing people familiar with the matter.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.